Ownership history in XTX Topco Ltd · 17 quarters on record
This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in PUMA BIOTECHNOLOGY INC (PBYI). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 25,524 | -78,900 | -75.6% | 0.01% | $136K | $5.31 |
| 2025 Q2 | REDUCED | 104,424 | -20,893 | -16.7% | 0.01% | $358K | $3.43 |
| 2025 Q1 | ADDED | 125,317 | +65,643 | +110.0% | 0.02% | $371K | $2.96 |
| 2024 Q4 | ADDED | 59,674 | +33,290 | +126.2% | 0.01% | $182K | $3.05 |
| 2024 Q3 | REDUCED | 26,384 | -22,227 | -45.7% | 0.00% | $67K | $2.55 |
| 2024 Q2 | REDUCED | 48,611 | -5,542 | -10.2% | 0.01% | $158K | $3.26 |
| 2024 Q1 | REDUCED | 54,153 | -739 | -1.3% | 0.04% | $287K | $5.30 |
| 2023 Q4 | ADDED | 54,892 | +39,603 | +259.0% | 0.05% | $238K | $4.33 |
| 2023 Q3 | REDUCED | 15,289 | -63,161 | -80.5% | 0.01% | $40K | $2.63 |
| 2023 Q2 | REDUCED | 78,450 | -3,169 | -3.9% | 0.05% | $277K | $3.53 |
As of 2025 Q4 — sorted by position size